|
Bayer Cropscience Limited (BayerCrop.NS) DCF -Bewertung
IN | Basic Materials | Agricultural Inputs | NSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Bayer CropScience Limited (BAYERCROP.NS) Bundle
Unabhängig davon, ob Sie ein Investor oder ein Analyst sind, ist dieser (BayerCropns) DCF-Taschenrechner Ihr Anlaufwerk für eine genaue Bewertung. Mit echten Daten von Bayer Cropscience Limited können Sie Prognosen anpassen und die Auswirkungen sofort beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35,190.0 | 41,428.0 | 45,767.0 | 51,397.0 | 51,032.0 | 50,918.8 | 50,805.8 | 50,693.1 | 50,580.6 | 50,468.4 |
| Revenue Growth, % | 0 | 17.73 | 10.47 | 12.3 | -0.71016 | -0.22187 | -0.22187 | -0.22187 | -0.22187 | -0.22187 |
| EBITDA | 6,618.0 | 8,801.0 | 9,237.0 | 10,914.0 | 10,345.0 | 10,360.9 | 10,337.9 | 10,315.0 | 10,292.1 | 10,269.3 |
| EBITDA, % | 18.81 | 21.24 | 20.18 | 21.23 | 20.27 | 20.35 | 20.35 | 20.35 | 20.35 | 20.35 |
| Depreciation | 649.0 | 730.0 | 640.0 | 790.0 | 735.0 | 812.9 | 811.1 | 809.3 | 807.5 | 805.7 |
| Depreciation, % | 1.84 | 1.76 | 1.4 | 1.54 | 1.44 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| EBIT | 5,969.0 | 8,071.0 | 8,597.0 | 10,124.0 | 9,610.0 | 9,548.0 | 9,526.8 | 9,505.7 | 9,484.6 | 9,463.6 |
| EBIT, % | 16.96 | 19.48 | 18.78 | 19.7 | 18.83 | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 |
| Total Cash | 11,077.0 | 12,567.0 | 8,194.0 | 9,189.0 | 12,107.0 | 12,354.8 | 12,327.4 | 12,300.0 | 12,272.8 | 12,245.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7,408.0 | 7,549.0 | 10,047.0 | 9,756.0 | 9,601.0 | 10,084.1 | 10,061.7 | 10,039.4 | 10,017.1 | 9,994.9 |
| Account Receivables, % | 21.05 | 18.22 | 21.95 | 18.98 | 18.81 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 |
| Inventories | 9,635.0 | 13,251.0 | 15,120.0 | 18,072.0 | 15,452.0 | 16,074.4 | 16,038.7 | 16,003.1 | 15,967.6 | 15,932.2 |
| Inventories, % | 27.38 | 31.99 | 33.04 | 35.16 | 30.28 | 31.57 | 31.57 | 31.57 | 31.57 | 31.57 |
| Accounts Payable | 4,749.0 | 8,303.0 | 8,198.0 | 8,732.0 | 6,051.0 | 8,177.2 | 8,159.0 | 8,140.9 | 8,122.9 | 8,104.9 |
| Accounts Payable, % | 13.5 | 20.04 | 17.91 | 16.99 | 11.86 | 16.06 | 16.06 | 16.06 | 16.06 | 16.06 |
| Capital Expenditure | -413.0 | -420.0 | -554.0 | -773.0 | -457.0 | -590.4 | -589.1 | -587.8 | -586.5 | -585.2 |
| Capital Expenditure, % | -1.17 | -1.01 | -1.21 | -1.5 | -0.89552 | -1.16 | -1.16 | -1.16 | -1.16 | -1.16 |
| Tax Rate, % | 21.34 | 21.34 | 21.34 | 21.34 | 21.34 | 21.34 | 21.34 | 21.34 | 21.34 | 21.34 |
| EBITAT | 4,857.3 | 5,009.2 | 6,551.3 | 7,752.8 | 7,559.2 | 7,158.8 | 7,142.9 | 7,127.0 | 7,111.2 | 7,095.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -7,200.7 | 5,116.2 | 2,165.3 | 5,642.8 | 7,931.2 | 8,402.0 | 7,404.8 | 7,388.3 | 7,371.9 | 7,355.6 |
| WACC, % | 6.73 | 6.72 | 6.73 | 6.73 | 6.73 | 6.73 | 6.73 | 6.73 | 6.73 | 6.73 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 31,444.0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 7,650 | |||||||||
| Terminal Value | 280,483 | |||||||||
| Present Terminal Value | 202,548 | |||||||||
| Enterprise Value | 233,992 | |||||||||
| Net Debt | -11,097 | |||||||||
| Equity Value | 245,089 | |||||||||
| Diluted Shares Outstanding, MM | 45 | |||||||||
| Equity Value Per Share | 5,453.44 |
What You Will Get
- Authentic Bayer Data: Comprehensive financial information – including revenue and EBIT – derived from actual and projected figures.
- Complete Customization: Modify all key parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to assess how changes affect Bayer CropScience Limited’s fair value.
- Flexible Excel Template: Designed for quick alterations, scenario testing, and in-depth projections.
- Efficient and Precise: Avoid the hassle of creating models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Bayer CropScience Limited (BAYERCROPNS).
- WACC Calculator: Features a pre-configured Weighted Average Cost of Capital sheet with adjustable inputs.
- Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to align with your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Bayer CropScience Limited (BAYERCROPNS).
- Dashboard and Visualizations: Visual outputs that concisely summarize essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the Excel spreadsheet.
- Step 2: Examine Bayer CropScience Limited's (BAYERCROPNS) pre-filled financial information and forecasts.
- Step 3: Adjust key parameters such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify the assumptions.
- Step 5: Evaluate the outputs and leverage the findings for investment decisions.
Why Opt for This Calculator?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your analysis needs.
- Real-Time Updates: Instantly observe changes in Bayer’s valuation as you modify inputs.
- Preloaded Data: Comes equipped with Bayer's actual financial information for immediate analysis.
- Preferred by Experts: Employed by investors and analysts for informed decision-making.
Who Should Benefit from This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for assessing their portfolios.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decision-making within the organization.
- Consultants and Advisors: Deliver precise valuation insights for Bayer CropScience Limited (BAYERCROPNS) to their clients.
- Students and Educators: Utilize real-world data to enhance learning and practice financial modeling techniques.
- Agriculture Enthusiasts: Gain insights into how agricultural companies like Bayer are valued in the market.
Contents of the Template
- Preloaded BAYERCROPNS Data: Historical and projected financial information, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Expert-grade spreadsheets designed for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted fields for modifying revenue growth rates, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financial reports for in-depth analysis.
- Key Ratios: Metrics for profitability, leverage, and efficiency to assess performance.
- Dashboard and Charts: Visual representations of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.